Literature DB >> 30626933

The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.

Yuanyuan Liu1, Liquan Wang2, Hongjun Shi3.   

Abstract

Pre-eclampsia (PE) is a pregnancy-specific syndrome that is characterized by hypertension and proteinuria. The etiology of PE is not completely understood but is believed to involve placental insufficiency and maternal vascular damage. Growing evidence supports an important role for the apelin receptor (APJ) system in regulating cardiovascular physiology. There are two vertebrate APJ ligands, APELIN and ELABELA, both of which mediate vasodilatory functions. A recent study linked deficient ELABELA signaling and the development of PE, though the molecular mechanism remains largely unknown. In this review, we summarize the biological function of the ELABELA and APJ system in cardiovascular homeostasis and discuss the potential mechanisms by which ELABELA and APJ regulate placenta trophoblast invasion and vascular functions and participate in the development of PE.

Entities:  

Keywords:  APELIN; APJ signaling; ELABELA; Pre-eclampsia

Mesh:

Substances:

Year:  2019        PMID: 30626933     DOI: 10.1038/s41440-018-0193-3

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  92 in total

Review 1.  Immunology of pre-eclampsia.

Authors:  Christopher W G Redman; Ian L Sargent
Journal:  Am J Reprod Immunol       Date:  2010-03-23       Impact factor: 3.886

Review 2.  Pathogenesis of preeclampsia.

Authors:  Brett C Young; Richard J Levine; S Ananth Karumanchi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 3.  Apelin receptors: From signaling to antidiabetic strategy.

Authors:  C Chaves-Almagro; I Castan-Laurell; C Dray; C Knauf; P Valet; B Masri
Journal:  Eur J Pharmacol       Date:  2015-05-22       Impact factor: 4.432

4.  Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.

Authors:  Cheng Deng; Haidi Chen; Na Yang; Yi Feng; Aaron J W Hsueh
Journal:  J Biol Chem       Date:  2015-05-20       Impact factor: 5.157

5.  A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11.

Authors:  B F O'Dowd; M Heiber; A Chan; H H Heng; L C Tsui; J L Kennedy; X Shi; A Petronis; S R George; T Nguyen
Journal:  Gene       Date:  1993-12-22       Impact factor: 3.688

Review 6.  The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.

Authors:  Nigel A Chapman; Denis J Dupré; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2014-08-20       Impact factor: 3.626

Review 7.  Pathophysiology and Current Clinical Management of Preeclampsia.

Authors:  Lorena M Amaral; Kedra Wallace; Michelle Owens; Babbette LaMarca
Journal:  Curr Hypertens Rep       Date:  2017-08       Impact factor: 5.369

Review 8.  The biology of preeclampsia.

Authors:  Keizo Kanasaki; Raghu Kalluri
Journal:  Kidney Int       Date:  2009-08-05       Impact factor: 10.612

9.  Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.

Authors:  Melissa Cudmore; Shakil Ahmad; Bahjat Al-Ani; Takeshi Fujisawa; Heather Coxall; Kunal Chudasama; Luke R Devey; Stephen J Wigmore; Allyah Abbas; Peter W Hewett; Asif Ahmed
Journal:  Circulation       Date:  2007-03-26       Impact factor: 29.690

Review 10.  Apelin and energy metabolism.

Authors:  Chantal Bertrand; Philippe Valet; Isabelle Castan-Laurell
Journal:  Front Physiol       Date:  2015-04-10       Impact factor: 4.566

View more
  4 in total

1.  ERK/HIF-1α/VEGF pathway: a molecular target of ELABELA (ELA) peptide for attenuating cardiac ischemia-reperfusion injury in rats by promoting angiogenesis.

Authors:  Kamran Rakhshan; Masoomeh Sharifi; Fatemeh Ramezani; Yaser Azizi; Nahid Aboutaleb
Journal:  Mol Biol Rep       Date:  2022-09-21       Impact factor: 2.742

2.  A Case-Control Study of the APELA Gene and Hypertensive Disorders of Pregnancy.

Authors:  Naomi Shimada; Tomohiro Nakayama; Hiroshi Umemura; Kei Kawana; Tatsuo Yamamoto; Seisaku Uchigasaki
Journal:  Medicina (Kaunas)       Date:  2022-04-26       Impact factor: 2.948

3.  Elabela may regulate SIRT3-mediated inhibition of oxidative stress through Foxo3a deacetylation preventing diabetic-induced myocardial injury.

Authors:  Cheng Li; Xiao Miao; Shudong Wang; Yucheng Liu; Jian Sun; Quan Liu; Lu Cai; Yonggang Wang
Journal:  J Cell Mol Med       Date:  2020-11-26       Impact factor: 5.310

4.  Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study.

Authors:  Zheng Ma; Lei Zhao; Ye-Ping Zhang; Jiu-Chang Zhong; Xin-Chun Yang
Journal:  BMC Cardiovasc Disord       Date:  2021-08-12       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.